- Abstract:
-
Background
Schizophrenia is one of the most common, burdensome, and costly psychiatric disorders in adults worldwide. Antipsychotic drugs are its treatment of choice, but there is controversy about which agent should be used. We aimed to compare and rank antipsychotics by quantifying information from randomised controlled trials.
Methods
Expand abstract
We did a network meta-analysis of placebo-controlled and head-to-head randomised controlled trials... - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Accepted Manuscript
- Publisher:
- Elsevier Publisher's website
- Journal:
- Lancet Journal website
- Volume:
- 394
- Issue:
- 10202
- Pages:
- 939-951
- Publication date:
- 2019-07-11
- Acceptance date:
- 2019-04-25
- DOI:
- EISSN:
-
1474-547X
- ISSN:
-
0140-6736
- Pubs id:
-
pubs:994706
- URN:
-
uri:ce8bb547-4368-4899-8269-26aaf4d65087
- UUID:
-
uuid:ce8bb547-4368-4899-8269-26aaf4d65087
- Local pid:
- pubs:994706
- Copyright holder:
- Elsevier Ltd.
- Copyright date:
- 2019
- Notes:
- © 2019 Elsevier Ltd. All rights reserved. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/S0140-6736(19)31135-3
Journal article
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Actions
Authors
Funding
Bibliographic Details
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record